EXAGEN INC. - COMMON STOCK

Exagen Inc. Reports Second Quarter 2022 Results

04 8 2022 15:05:01 提供 Nasdaq GlobeNewswire

Exagen Inc. to Participate in the Canaccord Genuity 42nd Annual Growth Conference

25 7 2022 15:05:00 提供 Nasdaq GlobeNewswire

Exagen to Announce Second Quarter 2022 Financial Results on August 4, 2022

21 7 2022 15:05:00 提供 Nasdaq GlobeNewswire

Exagen Releases Largest Comparative Utility Study in Lupus Diagnostics Confirming AVISE® Lupus Delivers Unparalleled Utility

05 7 2022 07:25:00 提供 Nasdaq GlobeNewswire

Exagen Inc. Expands Coverage with MediNcrease

09 6 2022 07:25:00 提供 Nasdaq GlobeNewswire

Exagen Inc. to Participate in the William Blair 42nd Annual Growth Stock Conference

26 5 2022 15:05:00 提供 Nasdaq GlobeNewswire

Exagen Inc. Expands Coverage with Alivio Health, Partnering to Provide More Accurate Diagnostic Testing with AVISE® CTD and AVISE® Lupus

16 5 2022 15:05:00 提供 Nasdaq GlobeNewswire

Exagen Inc. Announces New PLA Code and Medicare Pricing for Proprietary AVISE® Lupus Test

11 5 2022 15:06:00 提供 Nasdaq GlobeNewswire

Exagen Inc. Reports First Quarter 2022 Results

11 5 2022 15:05:01 提供 Nasdaq GlobeNewswire

Exagen Announces Five-Week Campaign for Lupus Awareness Month

01 5 2022 11:00:00 提供 Nasdaq GlobeNewswire

Exagen to Announce First Quarter 2022 Financial Results on May 11, 2022

25 4 2022 15:05:00 提供 Nasdaq GlobeNewswire

Exagen Inc. to Participate in Investor Summit Group’s Q2 Conference

20 4 2022 15:05:00 提供 Nasdaq GlobeNewswire

Exagen Inc. Expands In-Network Access with Evolutions Healthcare Systems

30 3 2022 07:25:00 提供 Nasdaq GlobeNewswire

Exagen Inc. Expands In-Network Benefit with Additional 22.7 Million Lives

22 3 2022 15:06:00 提供 Nasdaq GlobeNewswire

Exagen Inc. Reports Fourth Quarter and Full Year 2021 Results

22 3 2022 15:05:00 提供 Nasdaq GlobeNewswire

Exagen Announces New Rheumatoid Arthritis Scientific Advisory Board

16 3 2022 15:05:00 提供 Nasdaq GlobeNewswire

Exagen Inc. to Participate in the 2022 KeyBanc Capital Markets Life Sciences and MedTech Investor Forum

09 3 2022 15:05:00 提供 Nasdaq GlobeNewswire

Exagen to Announce Fourth Quarter and Full Year Financial Results on March 22, 2022

08 3 2022 15:05:00 提供 Nasdaq GlobeNewswire

Exagen Inc. to Participate in the 2022 BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference

02 2 2022 15:05:00 提供 Nasdaq GlobeNewswire

Exagen Inc. and Queen Mary University of London Announce Exclusive License and Collaboration to Develop Novel Patented Molecular Signatures for Rheumatoid Arthritis Biologic Therapeutic Selection

09 1 2022 11:00:00 提供 Nasdaq GlobeNewswire